Version 1
: Received: 17 April 2020 / Approved: 19 April 2020 / Online: 19 April 2020 (06:56:09 CEST)
How to cite:
Gonzalez Paz, L.A.; Lossada, C.A.; Moncayo, L.S.; Romero, F.; Paz, J.L.; Vera-Villalobos, J.; Perez, A.E.; San-Blas, E.; Alvarado, Y.J. Molecular Docking and Molecular Dynamic Study of Two Viral Proteins Associated with SARS-CoV-2 with Ivermectin. Preprints2020, 2020040334. https://doi.org/10.20944/preprints202004.0334.v1.
Gonzalez Paz, L.A.; Lossada, C.A.; Moncayo, L.S.; Romero, F.; Paz, J.L.; Vera-Villalobos, J.; Perez, A.E.; San-Blas, E.; Alvarado, Y.J. Molecular Docking and Molecular Dynamic Study of Two Viral Proteins Associated with SARS-CoV-2 with Ivermectin. Preprints 2020, 2020040334. https://doi.org/10.20944/preprints202004.0334.v1.
Cite as:
Gonzalez Paz, L.A.; Lossada, C.A.; Moncayo, L.S.; Romero, F.; Paz, J.L.; Vera-Villalobos, J.; Perez, A.E.; San-Blas, E.; Alvarado, Y.J. Molecular Docking and Molecular Dynamic Study of Two Viral Proteins Associated with SARS-CoV-2 with Ivermectin. Preprints2020, 2020040334. https://doi.org/10.20944/preprints202004.0334.v1.
Gonzalez Paz, L.A.; Lossada, C.A.; Moncayo, L.S.; Romero, F.; Paz, J.L.; Vera-Villalobos, J.; Perez, A.E.; San-Blas, E.; Alvarado, Y.J. Molecular Docking and Molecular Dynamic Study of Two Viral Proteins Associated with SARS-CoV-2 with Ivermectin. Preprints 2020, 2020040334. https://doi.org/10.20944/preprints202004.0334.v1.
Abstract
The global pandemic caused by the new SARS-COV-2 coronavirus makes it necessary to search for drugs for its control. Within of this research it has been known that the ivermectin drug, a FDA-approved drugs which is formulated as an 80:20 mixture of ivermectin B1a and B1b and used commonly for parasitic infections, has an inhibitory effect on viruses, includes SARS-COV-2 at in vitro level. In the particular case of SARS-COV-2 its mechanism of action remains elusive and controversial. Interestingly, the energy of interaction of ivermectin with any of the proteins the SARS-CoV-2 and the possible structural alterations at the protein level that this drug can cause have not been reported. In this sense, we carried out a bioinformatics study with docking strategies and molecular dynamics to predict the binding and disturbance induced by ivermectin in proteins associated with SARS-CoV-2. We use DockThor and Molegro docking scores. The DockThor server and myPresto software were used to build complexes and dynamics studies, respectively. The results obtained suggested that ivermectin is capable of docking with the 3CL protease and the HR2 domain, and may promote structural changes in these proteins by inducing unfolding/folding. Specifically, ivermectin brings protease to a significantly more deployed conformational state and the HR2 domain to a more compact state compared to the native state. Finally, it is shown that B1a and B1b macrocyclic lactones have a behavior different from to each target protein. These results suggest a possible inhibitory effect against SARS-CoV-2 due to a synergistic role of this drug to spontaneously bind to two important proteins involve in the proliferation of this virus. However, more studies are required on this possible mechanism of action.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
,
,
,
,
